Baipharm
ChemLinkedMarketChemicalFoodCosmeticBaiPharm Agrochemical Japan
Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
INTERPRETATION
Generic Drug Application (ANDA) in China
May 18, 2022
Q&A
FAQ on Rare Disease Drugs (Orphan Drugs) in China
Apr 07, 2022
INTERPRETATION
How to Sell OTC Drugs to China Through Cross-Border E-Commerce
Mar 29, 2022
INTERPRETATION
Drug Application Fees for FY 2022 in China and the U.S.
Feb 11, 2022
INTERPRETATION
China's Marketing Authorization Holder (MAH) System
Nov 25, 2021
INTERPRETATION
China Biological Product Registration Classification
Oct 19, 2021
INTERPRETATION
China Chemical Drug Registration Classification
Oct 18, 2021
Q&A
FAQ on Aesthetic Medicines | China CMDE
Oct 18, 2021
INTERPRETATION
IVD Reagent Registration and Filing in China
Oct 08, 2021
INTERPRETATION
Medical Device Registration and Filing in China
Sep 18, 2021
REPORT
China Drug Evaluation Report 2020-Reform of Drug Review & Approval System
Aug 27, 2021
REPORT
China Drug Evaluation Report 2020-Disapproval Reasons
Aug 27, 2021
12 Next